Hennion & Walsh Asset Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-43,455
Closed -$53.5K – 970
2026
Q1
$53.5K Sell
43,455
-752
-2% -$1.31K ﹤0.01% 927
2025
Q4
$127K Sell
44,207
-583
-1% -$1.62K ﹤0.01% 919
2025
Q3
$182K Sell
44,790
-367
-0.8% -$1.47K 0.01% 923
2025
Q2
$176K Sell
45,157
-1,663
-4% -$5.24K 0.01% 899
2025
Q1
$135K Sell
46,820
-4,066
-8% -$16.5K 0.01% 850
2024
Q4
$209K Buy
50,886
+12,946
+34% +$56.6K 0.01% 822
2024
Q3
$170K Buy
37,940
+14,609
+63% +$68.6K 0.01% 844
2024
Q2
$127K Buy
+23,331
New +$147K 0.01% 828

Other funds holding DH

Hennion & Walsh Asset Management's DH Position: Q2 2026 in Review

Hennion & Walsh Asset Management sold out of Definitive Healthcare (DH) in Q2 2026, closing a stake of 43,455 shares — an estimated $53.5K sold.

Hennion & Walsh Asset Management first reported a position in DH in Q2 2024 and held it in 8 quarters. The position peaked at $209K in Q4 2024. 99 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Hennion & Walsh Asset Management reported no remaining Definitive Healthcare position as of Q2 2026 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 43,455 Definitive Healthcare shares in Q2 2026, an estimated $53.5K.
  • Hennion & Walsh Asset Management first reported a position in Definitive Healthcare in Q2 2024 and held it in 8 quarters.
  • Hennion & Walsh Asset Management's Definitive Healthcare position peaked at $209K in Q4 2024.
  • 99 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.